(Date:12/1/2008)...ll/ -- Vanda Pharmaceuticals Inc. (Nasdaq: VNDA ...world,s leading medical journals, results of clini...imental compound tasimelteon (VEC-162). The publi...in agonist tasimelteon (VEC-162) for transient ins...olled multicentre trials." Results are reported fr...
(Date:12/1/2008)...wo-way switch that, if turned off, causes lymphati...y lose their identity and become more like blood e... Scientists at St. Jud...t a certain differentiated cell type is so ready t...t expression of a gene called Prox1 to dissuade ...
(Date:12/1/2008)...GeoVax Labs, Inc.,(OTC Bulletin Board: GOVX), an ...man vaccines for diseases caused by HIV-1 (Human I...s, announced today that the launch of its Phase 2a...ites across North and South America.,These trials...Institutes of,Health (NIH), and the HIV Vaccine T...
(Date:11/28/2008)...l/ -- Eli Lilly and Company,(NYSE: LLY ) has wi...A) from,the U.S. Food and Drug Administration (FD...ement of chronic pain. Lilly plans to resubmit the...ta from a recently completed positive study,in ch...e decision does not affect duloxetine,s FDA-approv...
Breaking Medicine Technology:Clinical Trial Results on the Sleep-Promoting Effects of Vanda Pharmaceuticals' Circadian Regulator Tasimelteon (VEC-162) Published in The Lancet 2Clinical Trial Results on the Sleep-Promoting Effects of Vanda Pharmaceuticals' Circadian Regulator Tasimelteon (VEC-162) Published in The Lancet 3Clinical Trial Results on the Sleep-Promoting Effects of Vanda Pharmaceuticals' Circadian Regulator Tasimelteon (VEC-162) Published in The Lancet 4Reprogrammable Cell Type Depends on a Single Gene to Keep Its Identity 2Reprogrammable Cell Type Depends on a Single Gene to Keep Its Identity 3GeoVax's Phase 2a HIV/AIDS Vaccine Human Trials to Begin in North and South America 2GeoVax's Phase 2a HIV/AIDS Vaccine Human Trials to Begin in North and South America 3Lilly Withdraws Application for Additional U.S. Indication for Cymbalta(R) for Chronic Pain 2Lilly Withdraws Application for Additional U.S. Indication for Cymbalta(R) for Chronic Pain 3Lilly Withdraws Application for Additional U.S. Indication for Cymbalta(R) for Chronic Pain 4Gilead to Topple GSK as the Top Player in the Anti Infectives Drug Market in 2014 9132 1Gilead to Topple GSK as the Top Player in the Anti Infectives Drug Market in 2014 9132 2Gilead to Topple GSK as the Top Player in the Anti Infectives Drug Market in 2014 9132 3Forterus Inc Announces Stock Buyback 29598 1Forterus Inc Announces Stock Buyback 29598 2The Quantum Group Announces Continued Growth of Patient Base and Preliminary Revenue Guidance 29596 1The Quantum Group Announces Continued Growth of Patient Base and Preliminary Revenue Guidance 29596 2The Quantum Group Announces Continued Growth of Patient Base and Preliminary Revenue Guidance 29596 3The Quantum Group Announces Continued Growth of Patient Base and Preliminary Revenue Guidance 29596 4Innovative Wellness Project Launched in Four Maine School Districts 29592 1Innovative Wellness Project Launched in Four Maine School Districts 29592 2...hicago, IL -- CytImmune, a clinical stage nanomedi...cialization of,multifunctional, tumor-targeted the...rd American Society of Clinical Oncology (ASCO),An...sults of a,Phase 1 Clinical Trial of CYT-6901," an...Institute conducted and CytImmune Sciences,sponsor...
...AION AG and US Partner Forest Laboratories, Inc. T...(Desmoteplase In Acute,Ischemic Stroke) Study with... 31st, 2007 - PAION AG (Frankfurt Stock,Exchange, ...oratories, Inc. (NYSE: FRX) today announced toplin...hemic Stroke) study with the,compound Desmoteplase...
Other Medicine Technology:CytImmune Presents Positive CYT-6019 Data During the American,Society of Clinical Oncology Annual Meeting in Chicago 2CytImmune Presents Positive CYT-6019 Data During the American,Society of Clinical Oncology Annual Meeting in Chicago 3Top Line Results of Phase III Study in Acute Ischemic Stroke,(DIAS-2) Do Not Demonstrate Difference Between Desmoteplase and,Placebo 2Top Line Results of Phase III Study in Acute Ischemic Stroke,(DIAS-2) Do Not Demonstrate Difference Between Desmoteplase and,Placebo 3Top Line Results of Phase III Study in Acute Ischemic Stroke,(DIAS-2) Do Not Demonstrate Difference Between Desmoteplase and,Placebo 4(Date:12/2/2008)... 2 The Healthcare group at,Frost ... is pleased to announce that,it will be hosting a...,sub-Saharan Africa on Friday 12 December at 16h0...om.com/cgi-bin/prnh/20081117/FSLOGO ) , Med...services is a,relatively novel concept in most su...
(Date:12/2/2008)...athon Health, a leading provider of onsite health ...hat New Balance, the athletic products company, ha...nd manage onsite health clinics and to provide hea...in Maine , Burlington, VT...ading provider of onsite employee health services ...
(Date:12/2/2008)... many families, the problem with the holidays is f...ight into how caregivers of aging parents can brin...experience. , San Mateo, ...he stress of the holiday season is family, especia...xpert Esther Koch , founder of Encore Management...
(Date:12/2/2008)...ional Non-profit Launches Age-related Macular Dege...ost to Eligible Patients and Free Eye-Healthy Cook... (Vocus) December 2, 2008 -- "Do You See What...isease known as Age-related Macular Degeneration (... ,Picture this…. a large black hole in the ...
Breaking Medicine News(10 mins):Health News:The Future of Financing Health Services in Africa 2Health News:Marathon Health Joins Forces with New Balance for Employee Health - Associate Health Services Provided at Three Maine Locations 2Health News:Marathon Health Joins Forces with New Balance for Employee Health - Associate Health Services Provided at Three Maine Locations 3Health News:Holidays with Aging Parents: Elder Care Expert Has the Prescription for Caregiver Stress 2Health News:Holidays with Aging Parents: Elder Care Expert Has the Prescription for Caregiver Stress 3Health News:This Holiday Season EyeCare America Asks Seniors, 'Do you see what I see?' 2Health News:This Holiday Season EyeCare America Asks Seniors, 'Do you see what I see?' 3Product includes all 15 Lexi-Comps databases. Includes Lexi-drugs, the official reference of the American Pharmacists Association and the National Professional Society of Pharmacists.
...fety Knife with BD Xstar Blade includes a speciall...tects the blade in prodedure and handling. The Xs...ess for manufacturing surgical blades. This propr...nsistency. The arch style, single-bevel geometry ...
Electric high speed system.
The Durafuge 100 spins swing-out rotors at 4000 rpm and fixed-angle rotors at up to 6300 rpm.
Medicine Products: